EGAS00001001778-sc-20160427 - samples
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
KRAS mutant CRC is currently in clinical trial with a combination of a MEK and Akt inhibitor. These patients will likely develop resistance to this combination. We aim to identify the mechanisms of resistance via ENU mutagenesis, with a view to identifying additional therapeutics which have the ability to overcome this resistance.EGA dataset EGAD00001002066
创建时间：
2017-07-26
